Abiopharma

🔍 WILSON KAREN J (Director)

Company: Serina Therapeutics, Inc. (SER)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 5,100 shares of Common Stock at $1.745 per share (Direct)
  Date: 2026-06-11 | Code: P | equity_swap_involved: 0 | shares_owned_after: 5,100.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,000 shares of Common Stock at $1.77 per share (Direct)
  Date: 2026-06-12 | Code: P | equity_swap_involved: 0 | shares_owned_after: 10,100.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.745 per share to a high purchase price of $1.75 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.
• F2: The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.76 per share to a high purchase price of $1.77 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price.